2012-11-14,AbSorber announces that Abteilung Transplantationsimmunologie at Institut für Immunologie, Universität Heidelberg, Germany now operates as a reference laboratory for XM-ONE® testing in Germany and other European countries.
XM-ONE® provides additional information compared to the currently used lymphocyte crossmatch tests and therefore improves the basis for risk assessment prior to transplantation.
|Product name||No. Of tests||List price|
|XM-ONE® Transplantation crossmatch||4||Inquire|
Accuracy and standardization of crossmatch results between different centers are essential in organ transplantation. The XM-ONE® proficiency testing (PT) program serves as an important function in accomplishing this goal. The PT program for XM-ONE® is approved by The American Society for Histocompatibility and Immunogenetics (ASHI).
The study showed that the XM-ONE® test can detect an antibody population not possible to detect with lymphocyte crossmatch tests that is strongly associated with rejection episodes and reduced kidney function after transplantation. Thus the XM-ONE® test can identify patients at risk of antibody-mediated rejections.